Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Regeneron Pharmaceuticals, Inc.
(NQ:
REGN
)
256.81
USD
-5.61 (-2.14%)
Streaming Delayed Price
/ Updated:
12:46 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Regeneron Pharmaceuticals, Inc.
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
Roth Capital Upgrades Regeneron Pharma (REGN) to Neutral
April 07, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6416546 for the full story.
Read More
from
StreetInsider.com News Articles
Recent 52-Week High Exceeded in Shares of Regeneron Pharmaceuticals (REGN)
April 05, 2011
from
Comtex SmarTrend® News Briefs
SmarTrend Detects Potential Break Out In Shares of Regeneron Pharmaceuticals (REGN)
April 04, 2011
from
Comtex SmarTrend® News Briefs
The Five Best Performing Biotech Stocks of 2011 -- So Far
April 01, 2011
Pharmaceuticals are facing big patent cliff problems this year, but several biotechnology stocks have been doing quite well: Their biologic drugs command high prices, tend become blockbusters, and they...
Read More
category
Cubist Pharmaceuticals
,
Arcalyst
,
3TC
, and 31 more.
from
DailyFinance.com
Head-to-head eye drug results tipped for early May
March 30, 2011
* Lucentis vs Avastin study may feature at May 1-5 congress
Read More
category
companyNews
from
Reuters: Company News
Biotech Stocks Could See Action On Valeant (VRX) Bid for Cephalon (CEPH): (BIIB) (JAZZ) (DNDN) (REGN) (more...)
March 29, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6395237 for the full story.
Read More
from
StreetInsider.com News Articles
SmarTrend's Trend Spotter Sees Continued Upward Momentum on Shares of Regeneron Pharmaceuticals (REGN)
March 28, 2011
from
Comtex SmarTrend® News Briefs
Recent 52-Week High Exceeded in Shares of Regeneron Pharmaceuticals (REGN)
March 28, 2011
from
Comtex SmarTrend® News Briefs
SmarTrend Detects Potential Break Out In Shares of Regeneron Pharmaceuticals (REGN)
March 24, 2011
from
Comtex SmarTrend® News Briefs
Regeneron Pharmaceuticals Upward Momentum Looks to Continue (REGN)
March 21, 2011
from
Comtex SmarTrend® News Briefs
Barclays Reiterates an 'Overweight' on Regeneron Pharma (REGN); Positive Feedback on VTE at Retinal Expert Meeting
March 16, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6371596 for the full story.
Read More
from
StreetInsider.com News Articles
Regeneron Pharmaceuticals Upward Momentum Looks to Continue (REGN)
March 15, 2011
from
Comtex SmarTrend® News Briefs
Barclays Maintains an 'Overweight' on Regeneron Pharma (REGN); Limited Impact From VITAL Results
March 11, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6362183 for the full story.
Read More
from
StreetInsider.com News Articles
Needham & Company Maintains a 'Buy' on Regeneron Pharma (REGN); Failed Aflibercept Trial in 2nd-line Lung Cancer Doesn’t Change Our Thesis
March 11, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6361443 for the full story.
Read More
from
StreetInsider.com News Articles
Sanofi-aventis (SNY), Regeneron (REGN) Reports Adding Aflibercept to Docetaxel Misses Primary Endpoint in NSCLC Study
March 10, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6360051 for the full story.
Read More
from
StreetInsider.com News Articles
Investors Bid Up Shares of Regeneron Pharmaceuticals, Up 1.9% (REGN)
March 09, 2011
from
Comtex SmarTrend® News Briefs
SmarTrend Detects Potential Break Out In Shares of Regeneron Pharmaceuticals (REGN)
March 08, 2011
from
Comtex SmarTrend® News Briefs
Earnings Flashback: Since Reporting Quarterly Results 14 Days Ago Regeneron Pharmaceuticals Is Up 1.39% (REGN)
March 07, 2011
from
Comtex SmarTrend® News Briefs
Analyst Rating In Review: Regeneron Pharmaceuticals Bid Up 4.28% Since Upgraded 7 Days Ago (REGN)
March 04, 2011
from
Comtex SmarTrend® News Briefs
Regeneron Pharmaceuticals: The Trend Continues Up (REGN)
March 03, 2011
from
Comtex SmarTrend® News Briefs
Barclays Reiterates an 'Overweight' on Regeneron Pharma (REGN); Second Gout Phase 3 Trial Positive
March 01, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6333666 for the full story.
Read More
from
StreetInsider.com News Articles
Regeneron's (REGN) ARCALYST Meets Primay, Secondary Endpoints in Recent Phase 3
February 28, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6327824 for the full story.
Read More
from
StreetInsider.com News Articles
Regeneron Pharmaceuticals Shares Creeping Higher, Up 1.6% (REGN)
February 25, 2011
from
Comtex SmarTrend® News Briefs
Regeneron Pharmaceuticals: The Trend Continues Up (REGN)
February 24, 2011
from
Comtex SmarTrend® News Briefs
RBC Capital Upgrades Biogen (BIIB), Regeneron (REGN) to Outperform, Downgrades Celgene (CELG) to Sector Perform
February 24, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6320387 for the full story.
Read More
from
StreetInsider.com News Articles
Regeneron Pharmaceuticals (REGN) Upgrade Alert, Watch for 22.6% Technical Uptrend Continuation
February 24, 2011
from
Comtex SmarTrend® News Briefs
Regeneron Pharmaceuticals (REGN) New Coverage Alert, Watch for 32.1% Technical Uptrend Reversal
February 23, 2011
from
Comtex SmarTrend® News Briefs
Stifel Nicolaus Starts Regeneron Pharma (REGN) at Hold
February 23, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6316314 for the full story.
Read More
from
StreetInsider.com News Articles
Regeneron (REGN) Submits BLA for VEGF Trap-Eye
February 22, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6312369 for the full story.
Read More
from
StreetInsider.com News Articles
Needham & Company maintains a 'Buy' on Regeneron Pharma (REGN); Believe 2011 Will Build on Successes of 2010
February 17, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6307279 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here